Congratulations to the team at Google DeepMind on launching #AlphaProteo, an AI system that could improve our understanding of biological processes. This system advances biological and health research, by supporting scientists in their creation of novel proteins that successfully bind to target molecules. Our scientists at Isomorphic Labs are excited to explore this model in application to drug design.
Introducing AlphaProteo: an AI system for designing novel proteins that bind more successfully to target molecules. 🧬 This research could help deepen our understanding of fundamental biology. Here’s how: 🔵 Protein binders are essential tools in drug development and biotech. They’ve already demonstrated potential in binding cancer cells, blocking viral infections and more. 🔵 AlphaProteo managed to generate candidates with strong binding to 7️⃣ diverse proteins related to infection, cancer, inflammation, and autoimmune disease. 🔵 AI for protein design has great potential - but more work is needed. We’re improving AlphaProteo’s success rate and will continue working with scientists to develop a responsible offering for the community. Find out more ↓https://dpmd.ai/4geFM0L
Is it available to all Scientific community for free? Where?
it looks like ubiquitin in this example ? 😅
This tech is moving so quickly.. good job we have candidates keeping up 😉 Ellie Cockburn
Thank You for sharing Isomorphic Labs
Very interesting and fast moving tech!
Inspiring!
Fascinating - Lauris Kemp this looks like your kind of science!
Building advanced AI teams and solutions. CTO, genAI.
1wWhat do you do about the metallic active sites?